CSL and Alentis will work together to progress antifibrotic drug, lixudebart across multiple rare kidney and liver diseases.

AstraZeneca has opened a new global strategic R&D facility in Massachusetts, US, as part of an investment of more than $1bn in the state.

The Nobel Prize committee says that optogenetics will lay the foundations for a new era in neuroscience, as pharma explores its role on treating ophthalmic conditions.

Illustration of New Albany International Business Park. Credit: Bayer AG. This investment adds to more than $7bn spent by the company on pharmaceutical research, development, and manufacturing in the ...

Summit is currently developing Ivonescimab in combination with other drugs across several types of solid tumours.

Unlike other therapies in this class, Abogen’s ABO2203 is designed to produce a T-cell engager protein in vivo through an mRNA-encoded system.

Key themes of CPHI 2026, the GLP-1 manufacturing shift, cold chain logistics, and more.

Having already brought one of the most successful drugs in the world to market, Sanofi and Regeneron are broadening their pipeline horizon – the companies have agreed to expand ...

Varda secures this capital as drugmakers tout the potential of manufacturing in microgravity conditions to create differentiated medicines.

The US FDA has expanded the approved indication for BMS' Camzyos to treat symptomatic oHCM in adults and paediatric patients weighing at least 30 kg.

BioMarin will screen and evaluate the computational outputs, with the objective of advancing selected candidates into preclinical testing. Credit: agustin.photo / Shutterstock.com. BioMarin ...